According to MaxCyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.1539. At the end of 2023 the company had a P/S ratio of 11.8.
Year | P/S ratio | Change |
---|---|---|
2023 | 11.8 | -6.34% |
2022 | 12.6 | -58.63% |
2021 | 30.4 |